Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats

BACKGROUND: Pioglitazone is a thiazolidinedione (TZD) insulin sensitizer approved for use in human type 2 diabetes mellitus. Therapeutic options for diabetes in cats are limited. OBJECTIVE: To evaluate the effects of pioglitazone in obese cats, which are predisposed to insulin resistance, to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, M., Thomaseth, K., Dirikolu, L., Ferguson, D. C., Hoenig, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Standard Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895531/
https://www.ncbi.nlm.nih.gov/pubmed/24592408
http://dx.doi.org/10.1111/jvim.12255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895531/
https://www.ncbi.nlm.nih.gov/pubmed/24592408
http://dx.doi.org/10.1111/jvim.12255

Ejemplares similares